- Home
- BMEA vs SERA Comparison
BMEA vs SERA Comparison
Compare BMEA & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- SERA
- Stock Information
- Founded
- BMEA 2017
- SERA 2008
- Country
- BMEA United States
- SERA United States
- Employees
- BMEA N/A
- SERA N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- SERA Precision Instruments
- Sector
- BMEA Health Care
- SERA Health Care
- Exchange
- BMEA Nasdaq
- SERA Nasdaq
- Market Cap
- BMEA 125.4M
- SERA N/A
- IPO Year
- BMEA 2021
- SERA 2021
- Fundamental
- Price
- BMEA $2.00
- SERA $3.43
- Analyst Decision
- BMEA Buy
- SERA
- Analyst Count
- BMEA 13
- SERA 0
- Target Price
- BMEA $27.92
- SERA N/A
- AVG Volume (30 Days)
- BMEA 636.9K
- SERA 103.1K
- Earning Date
- BMEA 05-01-2025
- SERA 03-19-2025
- Dividend Yield
- BMEA N/A
- SERA N/A
- EPS Growth
- BMEA N/A
- SERA N/A
- EPS
- BMEA N/A
- SERA N/A
- Revenue
- BMEA N/A
- SERA $77,000.00
- Revenue This Year
- BMEA $191.34
- SERA $4,536.36
- Revenue Next Year
- BMEA N/A
- SERA $411.43
- P/E Ratio
- BMEA N/A
- SERA N/A
- Revenue Growth
- BMEA N/A
- SERA N/A
- 52 Week Low
- BMEA $1.94
- SERA $3.33
- 52 Week High
- BMEA $14.43
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- BMEA 28.47
- SERA 32.89
- Support Level
- BMEA $2.27
- SERA $3.33
- Resistance Level
- BMEA $3.08
- SERA $4.20
- Average True Range (ATR)
- BMEA 0.23
- SERA 0.25
- MACD
- BMEA 0.00
- SERA -0.01
- Stochastic Oscillator
- BMEA 2.95
- SERA 10.99
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.